Showing results (11-20 of 2,699) with videos related to
Sort By:
Pageof 270
Critical Reviews in Microbiology|February 15, 2021
Candida albicans targets that potentially synergize with fluconazoleHui Lu, Manjari Shrivastava, Malcolm Whiteway, et al.Microbiological Research|May 14, 2021
Calcium-calcineurin signaling pathway in Candida albicans: A potential drug targetWanqian Li, Manjari Shrivastava, Hui Lu, et al.Journal of Global Antimicrobial Resistance|November 2, 2023
Understanding fluconazole tolerance in Candida albicans: implications for effective treatment of candidiasis and combating invasive fungal infectionsYanru Feng, Hui Lu, Malcolm Whiteway, et al.Frontiers in Pharmacology|May 9, 2025
Integrating ensemble machine learning and multi-omics approaches to identify Dp44mT as a novel anti-Candida albicans agent targeting cellular iron homeostasisXiaowei Chai, Yuanying Jiang, Hui Lu, et al.Current Microbiology|April 27, 2013
CaIPF19998 reduces drug susceptibility by enhancing the ability of biofilm formation and regulating redox homeostasis in Candida albicansXuanrong Sun, Hui Lu, Yuanying Jiang, et al.Antibiotics (Basel, Switzerland)|December 23, 2023
Unexpected Inhibitory Effect of Octenidine Dihydrochloride on Candida albicans Filamentation by Impairing Ergosterol Biosynthesis and Disrupting Cell Membrane IntegrityTing Fang, Juan Xiong, Li Wang, et al.Current Microbiology|March 9, 2016
Roles of RPS41 in Biofilm Formation, Virulence, and Hydrogen Peroxide Sensitivity in Candida albicansHui Lu, Juan Xiong, Qinghua Shang, et al.Advanced Drug Delivery Reviews|June 12, 2023
Candidiasis: From cutaneous to systemic, new perspectives of potential targets and therapeutic strategiesHui Lu, Ting Hong, Yuanying Jiang, et al.Vaccine|June 18, 2026
Recombinant subunit vaccines against invasive fungal infections: mechanisms, development progress, and therapeutic potentialXiaojing Xu, Bingchen Jiang, Juan Xiong, et al.Pharmaceutics|May 4, 2026
Antisense Oligonucleotides: Technological Advances, Clinical Progress, and Expanding Therapeutic FrontiersLiping Xu, Huaqun Zhang, Bingchen Jiang, et al.Pageof 270